<p>Optivise Advisory Services LLC 在第三季度购买了礼来公司（NYSE:LLY - 免费报告）的一项新股份，根据其最近向证券交易委员会的备案。该机构投资者购买了 1,954 股该公司的股票，价值约为 1,731,000 美元。礼来公司约占 Optivise Advisory Services LLC 投资组合的 0.9%，使其成为该公司第 27 大持股。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>3 只在第三季度业绩超预期且 2024 年指引强劲的顶级股票</li>
</ul>
<p>其他一些机构投资者和对冲基金最近也调整了他们对 LLY 的持股。Virtu Financial LLC 在第一季度购买了价值 213.8 万美元的礼来公司新头寸。Chesley Taft &amp; Associates LLC 在第二季度将其在礼来公司的持股增加了 5.4%。Chesley Taft &amp; Associates LLC 目前拥有 22,553 股该公司的股票，价值 2041.9 万美元，此前在上个季度购买了 1,163 股。OMNI 360 Wealth Inc. 在第二季度购买了价值约 239,000 美元的礼来公司新股份。Long Run Wealth Advisors LLC 在第二季度购买了价值约 209,000 美元的礼来公司新股份。最后，Essex Financial Services Inc. 在第二季度将其在礼来公司的持股增加了 5.8%。Essex Financial Services Inc. 目前拥有 28,183 股该公司的股票，价值 2551.7 万美元，此前在此期间购买了 1,556 股。82.53% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>礼来公司的内部交易</h2>
<p>在其他礼来公司的新闻中，首席会计官 Donald A. Zakrowski 于 11 月 8 日星期五出售了 900 股该公司的股票。股票以 803.38 美元的平均价格出售，总价值为 723,042.00 美元。交易完成后，首席会计官现在拥有 5,480 股该公司的股票，价值约为 4,402,522.40 美元。这代表了他们持股的 14.11% 的减少。该出售在与 SEC 的法律备案中披露，相关信息可通过此链接访问。公司内部人士持有该公司 0.13% 的股票。</p>
<h2>分析师的升级和降级</h2>
<ul>
<li>MarketBeat 周回顾 – 11/4 - 11/8</li>
</ul>
<p>多家研究公司对 LLY 进行了评估。Truist Financial 将礼来公司的目标价格从 1,000.00 美元提高至 1,033.00 美元，并在 10 月 10 日的研究报告中给予该股票 “买入” 评级。德意志银行将礼来公司的股票目标价格从 1,025.00 美元下调至 1,015.00 美元，并在 11 月 4 日的报告中为该公司设定了 “买入” 评级。Berenberg Bank 将礼来公司的股票目标价格从 1,000.00 美元提高至 1,050.00 美元，并在 8 月 14 日的研究报告中给予该股票 “买入” 评级。Sanford C. Bernstein 在 10 月 17 日的报告中开始覆盖礼来公司。他们给予该公司 “跑赢大盘” 的评级，并设定了 1,100.00 美元的价格目标。最后，Wolfe Research 在 11 月 15 日的报告中开始覆盖礼来公司。他们设定了 “跑赢大盘” 的评级，并为该股票设定了 1,000.00 美元的价格目标。四位分析师对该股票给予持有评级，十七位分析师对该公司给予买入评级。根据 MarketBeat.com 的数据，礼来公司的平均评级为 “适度买入”，平均价格目标为 1,007.94 美元。</p>
<p><strong>获取我们对礼来公司的最新股票分析</strong></p>
<h2>礼来公司的股票下跌 0.3%</h2>
<ul>
<li>Altimmune 如何在 GLP-1 市场中占据一席之地</li>
</ul>
<p>礼来公司的股票在周五开盘价为 748.01 美元。礼来公司的 12 个月低点为 561.65 美元，12 个月高点为 972.53 美元。该公司的 50 日简单移动平均为 865.01 美元，200 日简单移动平均为 869.01 美元。该公司的流动比率为 1.27，速动比率为 0.97，债务与股本比率为 2.03。该公司的市值为 7101 亿美元，市盈率为 80.87，PEG 比率为 2.84，贝塔值为 0.43。</p>
<p>礼来公司（NYSE:LLY - 获取免费报告）最近于 10 月 30 日星期三发布了季度财报。该公司报告季度每股收益为 1.18 美元，低于分析师一致预期的 1.52 美元，差额为 0.34 美元。该公司季度收入为 114.4 亿美元，而分析师预期为 120.9 亿美元。礼来公司的股本回报率为 71.08%，净利润率为 20.48%。该公司的收入与去年同期相比增长了 20.4%。在去年同期，该公司每股收益为 0.10 美元。分析师预测礼来公司今年将发布 13.2 美元的每股收益。</p>
<h2>礼来公司宣布分红</h2>
<p>该公司还最近宣布了一项季度分红，将于 12 月 10 日星期二支付。11 月 15 日星期五的登记投资者将获得每股 1.30 美元的分红。该分红的除息日为 11 月 15 日星期五。这代表着每年 5.20 美元的分红和 0.70% 的分红收益率。礼来公司的分红支付比率（DPR）目前为 56.22%。</p>
<h2>关于礼来公司</h2>
<p>（免费报告）</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>关于标记计算器</li>
<li>Vertiv 的酷炫科技让其股票火热</li>
<li>Roth IRA 计算器：计算您的潜在回报</li>
<li>MarketBeat 周报 – 11/18 - 11/22</li>
<li>3 只食品杂货股票可以帮助抵御通货膨胀</li>
<li>2 只具有竞争优势的金融股票，您无法忽视</li>
</ul>
<p><strong>想看看其他对 LLY 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 我不想说我早就告诉过你了（来自 WealthPress）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ5Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ5Mg"/></p>
<h2>您现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在您考虑礼来公司之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中有 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Optivise Advisory Services LLC 最近在礼来公司（NYSE: LLY）进行了约 731,000 美元的新投资，购买了 1,954 股。这项投资占 Optivise 投资组合的约 0.9%，在其持股中排名第 27 位。其他机构投资者也对 LLY 进行了调整，最近几个季度有显著的购买。分析师对礼来的股票进行了多次升级，普遍评级为 “适度买入”，平均目标价为 1,007.94 美元。该公司最近的财报显示每股收益为 1.18 美元，低于预期 0.34 美元</p>

<p>Optivise Advisory Services LLC bought a new stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,954 shares of the company's stock, valued at approximately $1,731,000. Eli Lilly and Company comprises approximately 0.9% of Optivise Advisory Services LLC's portfolio, making the stock its 27th biggest holding.</p>
<div class="lb-trans"><p>Optivise Advisory Services LLC 在第三季度购买了礼来公司（NYSE:LLY - 免费报告）的一项新股份，根据其最近向证券交易委员会的备案。该机构投资者购买了 1,954 股该公司的股票，价值约为 1,731,000 美元。礼来公司约占 Optivise Advisory Services LLC 投资组合的 0.9%，使其成为该公司第 27 大持股。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在第三季度业绩超预期且 2024 年指引强劲的顶级股票</li>
</ul>
</div><p>A number of other institutional investors and hedge funds have also recently modified their holdings of LLY. Virtu Financial LLC purchased a new position in Eli Lilly and Company during the first quarter worth $2,138,000. Chesley Taft &amp; Associates LLC grew its holdings in Eli Lilly and Company by 5.4% during the 2nd quarter. Chesley Taft &amp; Associates LLC now owns 22,553 shares of the company's stock valued at $20,419,000 after purchasing an additional 1,163 shares during the last quarter. OMNI 360 Wealth Inc. purchased a new stake in Eli Lilly and Company in the 2nd quarter worth about $239,000. Long Run Wealth Advisors LLC bought a new stake in Eli Lilly and Company in the second quarter worth about $209,000. Finally, Essex Financial Services Inc. boosted its position in shares of Eli Lilly and Company by 5.8% during the second quarter. Essex Financial Services Inc. now owns 28,183 shares of the company's stock valued at $25,517,000 after buying an additional 1,556 shares during the period. 82.53% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些机构投资者和对冲基金最近也调整了他们对 LLY 的持股。Virtu Financial LLC 在第一季度购买了价值 213.8 万美元的礼来公司新头寸。Chesley Taft &amp; Associates LLC 在第二季度将其在礼来公司的持股增加了 5.4%。Chesley Taft &amp; Associates LLC 目前拥有 22,553 股该公司的股票，价值 2041.9 万美元，此前在上个季度购买了 1,163 股。OMNI 360 Wealth Inc. 在第二季度购买了价值约 239,000 美元的礼来公司新股份。Long Run Wealth Advisors LLC 在第二季度购买了价值约 209,000 美元的礼来公司新股份。最后，Essex Financial Services Inc. 在第二季度将其在礼来公司的持股增加了 5.8%。Essex Financial Services Inc. 目前拥有 28,183 股该公司的股票，价值 2551.7 万美元，此前在此期间购买了 1,556 股。82.53% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Insider Transactions at Eli Lilly and Company</h2>
<div class="lb-trans"><h2>礼来公司的内部交易</h2>
</div><p>In other Eli Lilly and Company news, CAO Donald A. Zakrowski sold 900 shares of the company's stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $803.38, for a total value of $723,042.00. Following the completion of the transaction, the chief accounting officer now owns 5,480 shares in the company, valued at approximately $4,402,522.40. This represents a 14.11 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.13% of the company's stock.</p>
<div class="lb-trans"><p>在其他礼来公司的新闻中，首席会计官 Donald A. Zakrowski 于 11 月 8 日星期五出售了 900 股该公司的股票。股票以 803.38 美元的平均价格出售，总价值为 723,042.00 美元。交易完成后，首席会计官现在拥有 5,480 股该公司的股票，价值约为 4,402,522.40 美元。这代表了他们持股的 14.11% 的减少。该出售在与 SEC 的法律备案中披露，相关信息可通过此链接访问。公司内部人士持有该公司 0.13% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><ul>
<li>MarketBeat Week in Review – 11/4 - 11/8</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 11/4 - 11/8</li>
</ul>
</div><p>A number of research firms have weighed in on LLY. Truist Financial increased their target price on Eli Lilly and Company from $1,000.00 to $1,033.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, October 10th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Eli Lilly and Company from $1,025.00 to $1,015.00 and set a &#34;buy&#34; rating for the company in a report on Monday, November 4th. Berenberg Bank raised their target price on shares of Eli Lilly and Company from $1,000.00 to $1,050.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, August 14th. Sanford C. Bernstein assumed coverage on Eli Lilly and Company in a report on Thursday, October 17th. They issued an &#34;outperform&#34; rating and a $1,100.00 price target for the company. Finally, Wolfe Research began coverage on Eli Lilly and Company in a report on Friday, November 15th. They set an &#34;outperform&#34; rating and a $1,000.00 price objective on the stock. Four analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat.com, Eli Lilly and Company has an average rating of &#34;Moderate Buy&#34; and an average price target of $1,007.94.</p>
<div class="lb-trans"><p>多家研究公司对 LLY 进行了评估。Truist Financial 将礼来公司的目标价格从 1,000.00 美元提高至 1,033.00 美元，并在 10 月 10 日的研究报告中给予该股票 “买入” 评级。德意志银行将礼来公司的股票目标价格从 1,025.00 美元下调至 1,015.00 美元，并在 11 月 4 日的报告中为该公司设定了 “买入” 评级。Berenberg Bank 将礼来公司的股票目标价格从 1,000.00 美元提高至 1,050.00 美元，并在 8 月 14 日的研究报告中给予该股票 “买入” 评级。Sanford C. Bernstein 在 10 月 17 日的报告中开始覆盖礼来公司。他们给予该公司 “跑赢大盘” 的评级，并设定了 1,100.00 美元的价格目标。最后，Wolfe Research 在 11 月 15 日的报告中开始覆盖礼来公司。他们设定了 “跑赢大盘” 的评级，并为该股票设定了 1,000.00 美元的价格目标。四位分析师对该股票给予持有评级，十七位分析师对该公司给予买入评级。根据 MarketBeat.com 的数据，礼来公司的平均评级为 “适度买入”，平均价格目标为 1,007.94 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Eli Lilly and Company</strong></p>
<div class="lb-trans"><p><strong>获取我们对礼来公司的最新股票分析</strong></p>
</div><h2>Eli Lilly and Company Trading Down 0.3 %</h2>
<div class="lb-trans"><h2>礼来公司的股票下跌 0.3%</h2>
</div><ul>
<li>How Altimmune Could Grab a Big Chunk of the GLP-1 Market</li>
</ul>
<div class="lb-trans"><ul>
<li>Altimmune 如何在 GLP-1 市场中占据一席之地</li>
</ul>
</div><p>Shares of Eli Lilly and Company stock opened at $748.01 on Friday. Eli Lilly and Company has a 12-month low of $561.65 and a 12-month high of $972.53. The firm's 50 day simple moving average is $865.01 and its two-hundred day simple moving average is $869.01. The company has a current ratio of 1.27, a quick ratio of 0.97 and a debt-to-equity ratio of 2.03. The firm has a market capitalization of $710.10 billion, a price-to-earnings ratio of 80.87, a PEG ratio of 2.84 and a beta of 0.43.</p>
<div class="lb-trans"><p>礼来公司的股票在周五开盘价为 748.01 美元。礼来公司的 12 个月低点为 561.65 美元，12 个月高点为 972.53 美元。该公司的 50 日简单移动平均为 865.01 美元，200 日简单移动平均为 869.01 美元。该公司的流动比率为 1.27，速动比率为 0.97，债务与股本比率为 2.03。该公司的市值为 7101 亿美元，市盈率为 80.87，PEG 比率为 2.84，贝塔值为 0.43。</p>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.18 EPS for the quarter, missing analysts' consensus estimates of $1.52 by ($0.34). The firm had revenue of $11.44 billion for the quarter, compared to analyst estimates of $12.09 billion. Eli Lilly and Company had a return on equity of 71.08% and a net margin of 20.48%. The business's revenue was up 20.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.10 EPS. Analysts predict that Eli Lilly and Company will post 13.2 EPS for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最近于 10 月 30 日星期三发布了季度财报。该公司报告季度每股收益为 1.18 美元，低于分析师一致预期的 1.52 美元，差额为 0.34 美元。该公司季度收入为 114.4 亿美元，而分析师预期为 120.9 亿美元。礼来公司的股本回报率为 71.08%，净利润率为 20.48%。该公司的收入与去年同期相比增长了 20.4%。在去年同期，该公司每股收益为 0.10 美元。分析师预测礼来公司今年将发布 13.2 美元的每股收益。</p>
</div><h2>Eli Lilly and Company Announces Dividend</h2>
<div class="lb-trans"><h2>礼来公司宣布分红</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 10th. Investors of record on Friday, November 15th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $5.20 annualized dividend and a dividend yield of 0.70%. Eli Lilly and Company's dividend payout ratio (DPR) is presently 56.22%.</p>
<div class="lb-trans"><p>该公司还最近宣布了一项季度分红，将于 12 月 10 日星期二支付。11 月 15 日星期五的登记投资者将获得每股 1.30 美元的分红。该分红的除息日为 11 月 15 日星期五。这代表着每年 5.20 美元的分红和 0.70% 的分红收益率。礼来公司的分红支付比率（DPR）目前为 56.22%。</p>
</div><h2>About Eli Lilly and Company</h2>
<div class="lb-trans"><h2>关于礼来公司</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>About the Markup Calculator</li>
<li>Vertiv’s Cool Tech Makes Its Stock Red-Hot</li>
<li>Roth IRA Calculator: Calculate Your Potential Returns</li>
<li>MarketBeat Week in Review – 11/18 - 11/22</li>
<li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation</li>
<li>2 Finance Stocks With Competitive Advantages You Can't Ignore</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>关于标记计算器</li>
<li>Vertiv 的酷炫科技让其股票火热</li>
<li>Roth IRA 计算器：计算您的潜在回报</li>
<li>MarketBeat 周报 – 11/18 - 11/22</li>
<li>3 只食品杂货股票可以帮助抵御通货膨胀</li>
<li>2 只具有竞争优势的金融股票，您无法忽视</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LLY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 LLY 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ I hate to say I told you so (From WealthPress)(Ad)</p>
<div class="lb-trans"><p>→ 我不想说我早就告诉过你了（来自 WealthPress）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ5Mg" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10492&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Eli Lilly and Company right now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑礼来公司之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中有 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Optivise Advisory Services LLC 在礼来公司（NYSE:LLY）进行了新的 173 万美元投资